Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Hemorrhagic Fever Virus, Crimean-Congo | 2 | 2019 | 133 | 1.43 | Why? |
Ebolavirus | 9 | 2019 | 834 | 1.35 | Why? |
Hemorrhagic Fever, Ebola | 11 | 2019 | 1475 | 1.27 | Why? |
Colistin | 2 | 2017 | 217 | 1.14 | Why? |
Hemorrhagic Fever, Crimean | 2 | 2019 | 118 | 0.84 | Why? |
Bacterial Proteins | 3 | 2018 | 1318 | 0.82 | Why? |
Enterobacter aerogenes | 1 | 2017 | 24 | 0.73 | Why? |
Azabicyclo Compounds | 1 | 2019 | 91 | 0.72 | Why? |
Laboratory Proficiency Testing | 1 | 2019 | 85 | 0.72 | Why? |
Citrobacter freundii | 1 | 2017 | 14 | 0.71 | Why? |
Ceftazidime | 1 | 2019 | 134 | 0.70 | Why? |
Enterobacteriaceae Infections | 3 | 2018 | 529 | 0.68 | Why? |
Carbapenems | 2 | 2017 | 343 | 0.67 | Why? |
beta-Lactamases | 3 | 2019 | 759 | 0.66 | Why? |
Plasmids | 1 | 2017 | 840 | 0.53 | Why? |
Drug Resistance, Bacterial | 3 | 2019 | 1414 | 0.47 | Why? |
Klebsiella pneumoniae | 1 | 2017 | 658 | 0.45 | Why? |
Sierra Leone | 4 | 2018 | 267 | 0.42 | Why? |
Viral Matrix Proteins | 1 | 2017 | 1243 | 0.38 | Why? |
DNA, Viral | 3 | 2019 | 2521 | 0.37 | Why? |
Anti-Bacterial Agents | 4 | 2019 | 10083 | 0.37 | Why? |
Poxviridae Infections | 2 | 2018 | 31 | 0.36 | Why? |
Orthopoxvirus | 2 | 2018 | 29 | 0.36 | Why? |
Genetic Variation | 2 | 2019 | 3919 | 0.36 | Why? |
Software | 1 | 2019 | 2501 | 0.34 | Why? |
Phylogeny | 5 | 2020 | 13341 | 0.34 | Why? |
Molecular Diagnostic Techniques | 3 | 2020 | 4239 | 0.34 | Why? |
Point-of-Care Systems | 2 | 2017 | 2955 | 0.33 | Why? |
Monkey Diseases | 2 | 2018 | 190 | 0.31 | Why? |
Mutation | 3 | 2021 | 12376 | 0.30 | Why? |
Carbapenem-Resistant Enterobacteriaceae | 2 | 2018 | 214 | 0.29 | Why? |
Chikungunya virus | 2 | 2018 | 339 | 0.28 | Why? |
Computational Biology | 1 | 2019 | 4514 | 0.27 | Why? |
Chikungunya Fever | 2 | 2018 | 345 | 0.26 | Why? |
Real-Time Polymerase Chain Reaction | 4 | 2021 | 11367 | 0.25 | Why? |
Antigens, Viral | 3 | 2021 | 6298 | 0.23 | Why? |
Disease Outbreaks | 13 | 2020 | 27595 | 0.22 | Why? |
Laboratories | 3 | 2019 | 2858 | 0.21 | Why? |
RNA, Ribosomal, 16S | 2 | 2021 | 793 | 0.21 | Why? |
Microbial Sensitivity Tests | 3 | 2019 | 2886 | 0.21 | Why? |
Italy | 15 | 2021 | 38444 | 0.20 | Why? |
Zika Virus | 3 | 2017 | 1924 | 0.20 | Why? |
Containment of Biohazards | 2 | 2018 | 762 | 0.20 | Why? |
Macaca | 2 | 2018 | 388 | 0.20 | Why? |
T-Lymphocyte Subsets | 2 | 2017 | 1387 | 0.19 | Why? |
RNA, Viral | 5 | 2020 | 32276 | 0.19 | Why? |
Ixodidae | 1 | 2019 | 37 | 0.19 | Why? |
Zika Virus Infection | 3 | 2017 | 1920 | 0.18 | Why? |
Ticks | 1 | 2019 | 107 | 0.18 | Why? |
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2017 | 102 | 0.16 | Why? |
Vaccination | 3 | 2021 | 19050 | 0.16 | Why? |
Multilocus Sequence Typing | 1 | 2017 | 264 | 0.16 | Why? |
Croatia | 1 | 2017 | 360 | 0.16 | Why? |
Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.15 | Why? |
Measles virus | 1 | 2017 | 194 | 0.15 | Why? |
Biotechnology | 1 | 2019 | 444 | 0.15 | Why? |
Nose | 1 | 2021 | 1093 | 0.14 | Why? |
Sensitivity and Specificity | 4 | 2021 | 22971 | 0.14 | Why? |
Microcephaly | 1 | 2016 | 181 | 0.13 | Why? |
Blood Chemical Analysis | 1 | 2018 | 541 | 0.13 | Why? |
Geography | 1 | 2019 | 1801 | 0.13 | Why? |
Climate | 1 | 2018 | 557 | 0.13 | Why? |
Africa, Western | 3 | 2019 | 363 | 0.12 | Why? |
Drug Resistance, Multiple, Bacterial | 2 | 2019 | 1115 | 0.12 | Why? |
Oropharynx | 1 | 2021 | 1581 | 0.12 | Why? |
Klebsiella Infections | 1 | 2017 | 466 | 0.12 | Why? |
Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.11 | Why? |
Biological Specimen Banks | 1 | 2019 | 1142 | 0.11 | Why? |
Viremia | 1 | 2018 | 1020 | 0.11 | Why? |
Microbiota | 1 | 2021 | 1240 | 0.10 | Why? |
Security Measures | 1 | 2013 | 211 | 0.10 | Why? |
Humans | 40 | 2021 | 930598 | 0.10 | Why? |
Safety | 1 | 2018 | 1583 | 0.10 | Why? |
Escherichia coli | 1 | 2017 | 1547 | 0.10 | Why? |
Measles | 1 | 2017 | 608 | 0.10 | Why? |
Autoimmunity | 1 | 2017 | 841 | 0.10 | Why? |
Sequence Analysis, RNA | 1 | 2019 | 2290 | 0.10 | Why? |
Drug Combinations | 1 | 2019 | 3852 | 0.10 | Why? |
Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.09 | Why? |
Disease Reservoirs | 1 | 2018 | 1672 | 0.09 | Why? |
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3633 | 0.09 | Why? |
Gastrointestinal Microbiome | 1 | 2021 | 1961 | 0.08 | Why? |
Interferon-gamma | 1 | 2017 | 2711 | 0.08 | Why? |
Reagent Kits, Diagnostic | 1 | 2017 | 2149 | 0.08 | Why? |
Killer Cells, Natural | 1 | 2017 | 2093 | 0.08 | Why? |
Male | 19 | 2021 | 367725 | 0.08 | Why? |
Lung Transplantation | 1 | 2018 | 1554 | 0.08 | Why? |
Indomethacin | 1 | 2006 | 47 | 0.08 | Why? |
Biomedical Research | 2 | 2019 | 5270 | 0.07 | Why? |
Nucleic Acid Probes | 1 | 2005 | 38 | 0.07 | Why? |
Autoantibodies | 1 | 2017 | 2094 | 0.07 | Why? |
Caspases | 1 | 2005 | 156 | 0.07 | Why? |
Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 127 | 0.07 | Why? |
Immunoassay | 1 | 2021 | 4485 | 0.07 | Why? |
Animals | 11 | 2021 | 78931 | 0.07 | Why? |
Nucleic Acid Hybridization | 1 | 2005 | 140 | 0.07 | Why? |
Female | 18 | 2021 | 380317 | 0.07 | Why? |
Computer Simulation | 1 | 2019 | 4982 | 0.07 | Why? |
Safety Management | 1 | 2013 | 1093 | 0.07 | Why? |
Communicable Diseases, Emerging | 1 | 2019 | 2523 | 0.07 | Why? |
Mass Screening | 2 | 2021 | 8005 | 0.07 | Why? |
Viruses | 1 | 2017 | 2238 | 0.06 | Why? |
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 7868 | 0.06 | Why? |
Flow Cytometry | 2 | 2017 | 2393 | 0.06 | Why? |
Adult | 12 | 2021 | 244371 | 0.06 | Why? |
Endopeptidases | 1 | 2003 | 228 | 0.06 | Why? |
Time Factors | 4 | 2020 | 31397 | 0.06 | Why? |
Liver Transplantation | 1 | 2018 | 2864 | 0.06 | Why? |
CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.06 | Why? |
Immunoglobulin G | 4 | 2019 | 21571 | 0.06 | Why? |
Tuberculosis | 1 | 2018 | 2895 | 0.06 | Why? |
Respiratory Tract Infections | 2 | 2020 | 6817 | 0.06 | Why? |
Aged | 9 | 2021 | 215776 | 0.06 | Why? |
Civil Defense | 1 | 2013 | 1687 | 0.05 | Why? |
Nasopharynx | 1 | 2020 | 10224 | 0.05 | Why? |
Receptors, HIV | 1 | 1999 | 15 | 0.05 | Why? |
Delivery of Health Care | 2 | 2017 | 15909 | 0.05 | Why? |
Viral Load | 2 | 2018 | 15850 | 0.05 | Why? |
Nucleic Acids | 1 | 2005 | 435 | 0.05 | Why? |
Bacteria | 2 | 2021 | 1897 | 0.05 | Why? |
Hospitalization | 3 | 2021 | 54280 | 0.05 | Why? |
Erythrocyte Indices | 1 | 2020 | 207 | 0.05 | Why? |
Interferon-alpha | 2 | 2006 | 1442 | 0.05 | Why? |
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2019 | 13720 | 0.05 | Why? |
Mean Platelet Volume | 1 | 2020 | 203 | 0.05 | Why? |
Rome | 1 | 2020 | 497 | 0.05 | Why? |
Virus Diseases | 1 | 2017 | 3779 | 0.05 | Why? |
Middle Aged | 11 | 2021 | 270681 | 0.05 | Why? |
Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
Tandem Repeat Sequences | 1 | 2018 | 78 | 0.05 | Why? |
Oocytes | 1 | 1999 | 86 | 0.05 | Why? |
Housing, Animal | 1 | 2017 | 53 | 0.05 | Why? |
Cohort Studies | 5 | 2021 | 36005 | 0.05 | Why? |
SARS Virus | 4 | 2006 | 13021 | 0.04 | Why? |
Receptors, KIR2DL1 | 1 | 2017 | 23 | 0.04 | Why? |
Natural Cytotoxicity Triggering Receptor 1 | 1 | 2017 | 21 | 0.04 | Why? |
Prospective Studies | 2 | 2020 | 43301 | 0.04 | Why? |
Communicable Diseases | 1 | 2013 | 2148 | 0.04 | Why? |
Hospitals | 1 | 2017 | 11793 | 0.04 | Why? |
Muscles | 1 | 2018 | 152 | 0.04 | Why? |
West Indies | 1 | 2016 | 48 | 0.04 | Why? |
Bone Marrow | 1 | 2020 | 492 | 0.04 | Why? |
fas Receptor | 1 | 2017 | 85 | 0.04 | Why? |
Chaperonin 60 | 1 | 2017 | 42 | 0.04 | Why? |
Vero Cells | 4 | 2021 | 14117 | 0.04 | Why? |
Product Surveillance, Postmarketing | 1 | 2019 | 189 | 0.04 | Why? |
Guinea | 1 | 2017 | 228 | 0.04 | Why? |
Communicable Disease Control | 2 | 2017 | 29620 | 0.04 | Why? |
Granzymes | 1 | 2017 | 197 | 0.04 | Why? |
CD56 Antigen | 1 | 2017 | 193 | 0.04 | Why? |
Survivors | 2 | 2020 | 2619 | 0.04 | Why? |
Insect Vectors | 1 | 2018 | 227 | 0.04 | Why? |
Spleen | 1 | 2020 | 877 | 0.04 | Why? |
Epidemics | 1 | 2017 | 6407 | 0.04 | Why? |
Mitochondrial Proteins | 1 | 2017 | 152 | 0.04 | Why? |
Rodentia | 1 | 2017 | 235 | 0.04 | Why? |
CTLA-4 Antigen | 1 | 2017 | 282 | 0.04 | Why? |
Prevalence | 1 | 2017 | 25773 | 0.04 | Why? |
Apoptosis | 1 | 2005 | 2335 | 0.04 | Why? |
Cross Infection | 1 | 2017 | 8675 | 0.04 | Why? |
Blood Cell Count | 1 | 2020 | 1101 | 0.04 | Why? |
Europe | 3 | 2018 | 12702 | 0.04 | Why? |
Americas | 1 | 2016 | 418 | 0.04 | Why? |
Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
Pneumonia, Viral | 2 | 2020 | 243684 | 0.03 | Why? |
Aedes | 1 | 2018 | 380 | 0.03 | Why? |
Pandemics | 3 | 2021 | 389249 | 0.03 | Why? |
Measles Vaccine | 1 | 2017 | 301 | 0.03 | Why? |
DNA, Bacterial | 1 | 2018 | 835 | 0.03 | Why? |
Fetal Diseases | 1 | 2016 | 182 | 0.03 | Why? |
Child, Preschool | 4 | 2018 | 36283 | 0.03 | Why? |
Primates | 1 | 2017 | 584 | 0.03 | Why? |
Lung | 2 | 2020 | 31049 | 0.03 | Why? |
Demography | 1 | 2020 | 1660 | 0.03 | Why? |
Young Adult | 6 | 2021 | 93724 | 0.03 | Why? |
Bioterrorism | 1 | 2013 | 105 | 0.03 | Why? |
Antibodies, Viral | 4 | 2018 | 51949 | 0.03 | Why? |
Population Surveillance | 2 | 2020 | 4967 | 0.03 | Why? |
Aged, 80 and over | 5 | 2021 | 88759 | 0.03 | Why? |
Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
Vascular Diseases | 1 | 2020 | 846 | 0.03 | Why? |
Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
DNA | 1 | 2017 | 778 | 0.03 | Why? |
Infant | 3 | 2018 | 30274 | 0.03 | Why? |
Latin America | 1 | 2016 | 1721 | 0.03 | Why? |
Leukocyte Count | 1 | 2020 | 3178 | 0.03 | Why? |
Rats | 1 | 2017 | 2764 | 0.03 | Why? |
Immunoglobulin M | 2 | 2018 | 9091 | 0.02 | Why? |
Dengue Virus | 1 | 2017 | 910 | 0.02 | Why? |
Virus Replication | 3 | 2006 | 14331 | 0.02 | Why? |
Autopsy | 1 | 2020 | 3495 | 0.02 | Why? |
Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.02 | Why? |
ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
Child | 4 | 2018 | 70012 | 0.02 | Why? |
Tissue Donors | 1 | 2018 | 1679 | 0.02 | Why? |
Program Evaluation | 1 | 2017 | 1929 | 0.02 | Why? |
Mexico | 1 | 2016 | 2787 | 0.02 | Why? |
Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
Ribavirin | 2 | 2006 | 1182 | 0.02 | Why? |
Point-of-Care Testing | 1 | 2021 | 2782 | 0.02 | Why? |
Lymphocyte Activation | 1 | 2017 | 2742 | 0.02 | Why? |
Kidney | 1 | 2020 | 3648 | 0.02 | Why? |
Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
Liver | 1 | 2020 | 4007 | 0.02 | Why? |
Infant, Newborn | 2 | 2018 | 23105 | 0.02 | Why? |
Base Pair Mismatch | 1 | 2005 | 29 | 0.02 | Why? |
Biomarkers | 2 | 2020 | 23361 | 0.02 | Why? |
T-Lymphocytes | 1 | 2003 | 6670 | 0.02 | Why? |
Streptavidin | 1 | 2005 | 27 | 0.02 | Why? |
Polymerase Chain Reaction | 2 | 2017 | 6740 | 0.02 | Why? |
Skin | 1 | 2017 | 2096 | 0.02 | Why? |
Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
Microscopy, Phase-Contrast | 1 | 2004 | 10 | 0.02 | Why? |
Enkephalin, Leucine | 1 | 2003 | 2 | 0.02 | Why? |
HIV-1 | 1 | 1999 | 3365 | 0.02 | Why? |
Oligonucleotides | 1 | 2005 | 137 | 0.02 | Why? |
Immunity, Cellular | 1 | 2017 | 3614 | 0.02 | Why? |
Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
Blood Coagulation Disorders | 1 | 2018 | 2040 | 0.02 | Why? |
Neutrophils | 1 | 2020 | 5476 | 0.02 | Why? |
Immunoblotting | 1 | 2004 | 180 | 0.02 | Why? |
Chromatography, Thin Layer | 1 | 2003 | 37 | 0.02 | Why? |
Chromatography, Gel | 1 | 2003 | 71 | 0.02 | Why? |
World Health Organization | 1 | 2017 | 4213 | 0.02 | Why? |
Adolescent | 3 | 2018 | 86841 | 0.02 | Why? |
Microspheres | 1 | 2005 | 261 | 0.02 | Why? |
Hydrolysis | 1 | 2003 | 160 | 0.02 | Why? |
Immunity, Humoral | 1 | 2017 | 4849 | 0.02 | Why? |
Coronavirus, Canine | 1 | 2006 | 375 | 0.02 | Why? |
Algorithms | 1 | 2020 | 7346 | 0.02 | Why? |
Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
Cytopathogenic Effect, Viral | 1 | 2004 | 635 | 0.01 | Why? |
Antiviral Agents | 2 | 2006 | 41703 | 0.01 | Why? |
Transplant Recipients | 1 | 2018 | 4982 | 0.01 | Why? |
Specimen Handling | 1 | 2019 | 6190 | 0.01 | Why? |
Travel | 1 | 2020 | 7220 | 0.01 | Why? |
Fluorescent Dyes | 1 | 2005 | 536 | 0.01 | Why? |
Severe Acute Respiratory Syndrome | 1 | 2004 | 12361 | 0.01 | Why? |
Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.01 | Why? |
Receptors, CXCR4 | 1 | 1999 | 83 | 0.01 | Why? |
Dog Diseases | 1 | 2006 | 745 | 0.01 | Why? |
Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
Cell Line | 2 | 2006 | 12040 | 0.01 | Why? |
Brain | 1 | 2016 | 5133 | 0.01 | Why? |
Thrombosis | 1 | 2020 | 7504 | 0.01 | Why? |
Dogs | 1 | 2006 | 2529 | 0.01 | Why? |
CD4 Antigens | 1 | 1999 | 306 | 0.01 | Why? |
Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
Receptors, CCR5 | 1 | 1999 | 186 | 0.01 | Why? |
Aspirin | 1 | 2006 | 1043 | 0.01 | Why? |
HIV Infections | 1 | 2003 | 11620 | 0.01 | Why? |
Mice | 1 | 2017 | 21357 | 0.01 | Why? |
Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
Microscopy, Electron | 1 | 1999 | 830 | 0.01 | Why? |
Spermatozoa | 1 | 1999 | 244 | 0.01 | Why? |
Dose-Response Relationship, Drug | 1 | 2006 | 3776 | 0.01 | Why? |
Viral Vaccines | 1 | 2017 | 7560 | 0.01 | Why? |
Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
Influenza, Human | 1 | 2020 | 10779 | 0.01 | Why? |
Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
Recombinant Proteins | 1 | 2004 | 3786 | 0.01 | Why? |
Pregnancy | 1 | 2016 | 23879 | 0.01 | Why? |
Transcription, Genetic | 1 | 1999 | 1326 | 0.01 | Why? |
Feces | 1 | 2006 | 4235 | 0.01 | Why? |
Cells, Cultured | 1 | 2003 | 5835 | 0.01 | Why? |
Public Health | 1 | 2017 | 16359 | 0.01 | Why? |
Health Personnel | 1 | 2017 | 29646 | 0.00 | Why? |
RNA, Messenger | 1 | 1999 | 5131 | 0.00 | Why? |